Early evidence of success for a growing number of vaccine candidates is encouraging, but undue haste in vaccine approval is a threat to public health.

Declining to talk about industrial policies has not meant that the United States does not pursue them by other names and other means. It does mean that thoughtful approaches to industrial policy, supported by sound analysis, evidence-based reasoning, and vigorous open debate, have rarely been pursued.